Implantation of an Advanced Practice Nurse in the Complex Care Pathway of Patients With AML

NCT ID: NCT05309018

Last Updated: 2024-05-23

Basic Information

• Recruitment Status: WITHDRAWN
• Study Classification: OBSERVATIONAL
• Study Start Date: 2024-05-15
• Study Completion Date: 2024-12-15

Brief Summary

Advanced Practice Nurse (APN) is a new contributor in the French healthcare system. APN is part of a multidisciplinary team and aim to monitor patients under the coordination of the doctor particularly in onco-hematology. The aim of the study is to describe the different perceptions and expectations of APN monitoring according to patients with acute myeloid leukemia (AML) and their care team.

This study will involve 10 patients, recruited over a provisional period of 5 months and 25 member of care team. Patients and their care team will be asked about their perceptions and expectations of APN participation in (AML monitoring) during a semi-structured interviews.

Conditions

Myeloid Leukemia

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Patients

Interviews

Intervention Type: OTHER

Semi-structured interview about perceptions and expectations of APN participation in AML monitoring according to patient and to care team.

medical staff

Interviews

Intervention Type: OTHER

Semi-structured interview about perceptions and expectations of APN participation in AML monitoring according to patient and to care team.

Interventions

Interviews

Semi-structured interview about perceptions and expectations of APN participation in AML monitoring according to patient and to care team.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patient with AML
• Treated with a new targeted oral therapy as monotherapy or in combination:

• Venetoclax* in combination with ivosidenib (IDH1 inhibitor)
• Onureg* (azacitin: pyrimidine analogue)
• Venetoclax (BCL-2 protein inhibitor) in combination with subcutaneous azacitin
• Whose follow-up is provided alternately by a hematologist and an IPA.
• Affiliated to a social security scheme

Exclusion Criteria

• Moderate or severe cognitive impairment
• Language barrier
• Other communication disorders

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Centre Hospitalier Régional Metz-Thionville

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Jennifer HUET

Role: PRINCIPAL_INVESTIGATOR

CHR Metz Thionville Hopital de Mercy

Other Identifiers

2021-07Obs-CHRMT

Identifier Type: -

Identifier Source: org_study_id